Clinical trial
Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic…
NCT00361049 · Case Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00361049 |
|---|---|
| Title | Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant |
| Official title | Donor Mesenchymal Stem Cell Infusion for Treatment of Graft Versus Host Disease: A Phase I Trial |
| Lead sponsor | Case Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cancer |
| Intervention type | Biological, Genetic, Other, Procedure |
| Interventions | graft versus host disease prophylaxis/therapy, fluorescence in situ hybridization, immunoenzyme technique, immunohistochemistry staining method, laboratory biomarker analysis, in vitro-treated bone marrow transplantation, management of therapy complications |
| Enrollment | 49 |
| Start date | Sep 1, 2004 |
| Primary completion | Jun 1, 2009 |
| Completion | Nov 1, 2010 |
| First posted | Aug 7, 2006 |
| Last update posted | Nov 5, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: